Reliance Global Group, Inc. 8-K
Research Summary
AI-generated summary
Reliance Global Group Forms LGG, Invests $2.0M in Innervate
What Happened
- On April 29–30, 2026, Reliance Global Group, Inc. (EZRA) and affiliates formed LifeSci Global Group LLC (LGG) and completed LGG’s initial investment in Innervate Radiopharmaceuticals LLC. The Company holds approximately 51% of LGG; the remaining ~49% is held by LifeSci Management Group LLC (owned by Ezra Beyman, Scott Korman and David Turner). The transactions were reviewed and approved by the independent and disinterested members of the Company’s board.
- To support LGG, EZRA’s wholly owned subsidiary EZRA International Group LLC (EIG) and LGG entered a Promissory Note on April 29, 2026. On April 30, 2026, LGG entered a Unit Subscription Agreement and related Side Letter with Innervate for a private placement investment.
Key Details
- Company ownership: Reliance holds ~51% of LGG; Management Group holds ~49%.
- Promissory Note: up to $2,000,000 principal, 7% annual interest (compounded annually, accruing daily); payable on event of default or by April 29, 2031 (extendable by agreement).
- Subscription: LGG agreed to subscribe for up to 421,053 Class A units of Innervate at $4.75/unit (aggregate $2,000,001.75), payable in installments.
- Side Letter rights: LGG entitled to a one‑time priority distribution of $4.75 per unit from certain proceeds and warrants equal to 1 warrant per 2 units (cap 210,526 warrants), strike $4.75, expiration October 31, 2029. Units issued via a Regulation D, Rule 506(b) private placement.
Why It Matters
- The filings show EZRA has created a vehicle (LGG) to make healthcare investments and has committed funding (via EIG’s promissory note) to support a $2.0M investment in an early‑stage radiopharmaceutical company (Innervate).
- Investors get specific terms: minority equity exposure in Innervate, priority distribution rights, and warrants that could provide upside if Innervate achieves a liquidity event. The investment is private and in an early‑stage company, so liquidity and outcomes are uncertain. The company disclosed the transaction publicly via a press release and included the transaction documents as exhibits to the 8-K.
Loading document...